Continuous glucose monitoring device
Sponsors
TNO, Milton S. Hershey Medical Center, Institut de Recherches Cliniques de Montreal, Sinocare Meditech Inc., Tel-Aviv Sourasky Medical Center
Conditions
Continuous Glucose MonitoringDiabetes MellitusHealthyHyperglycemic DisorderHypoglycemia UnawarenessNeonatal HypoglycemiaNutritional, Metabolic, EndocrineObesity
Phase 4
Unknown Phase
Blood Glucose, Cognition and Wellbeing @ Work
CompletedNCT03295578
Start: 2017-10-02End: 2017-12-22Updated: 2020-03-24
Continuous Glucose Monitoring in At-Risk Newborns
RecruitingNCT04386005
Start: 2021-08-09End: 2026-06-30Target: 100Updated: 2025-08-15
Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training
CompletedNCT04825366
Start: 2021-08-03End: 2025-08-31Updated: 2026-01-08
A Pilot Study of the Feasibility and Accuracy of the TrueVie CGM System - A Non-Significant Risk Study
CompletedNCT05348928
Start: 2022-05-04End: 2022-06-16Updated: 2022-06-30
Correlation of CGM Metrics With OGTT and Pregnancy Outcomes in Pregnant Women With or Without a High Risk for GDM
NCT05537480
Start: 2022-01-14End: 2024-11-01Target: 280Updated: 2022-09-13
Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
CompletedNCT05806554
Start: 2023-07-19End: 2024-10-22Updated: 2025-11-25
Optimizing Weight Loss. Can Continuous Glucose Monitoring Play a Role
Active, not recruitingNCT05890209
Start: 2023-04-15End: 2024-10-15Updated: 2024-05-16